(Q46490039)

English

Blood miRNA expression pattern is a possible risk marker for natalizumab-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients.

scientific article published on 22 May 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Blood miRNA expression pattern is a possible risk marker for natalizumab-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

multiple sclerosis

0 references

microRNA expression

0 references

progressive multifocal leukoencephalopathy

0 references

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Adolfo López de Munain

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Tamara Castillo-Triviño

3

object named as

T Castillo-Triviño

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

author name string

M Muñoz-Culla

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

H Irizar

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

M Sáenz-Cuesta

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

L Sepúlveda

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

I Lopetegi

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

J Olascoaga

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

S E Baranzini

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

publication date

22 May 2014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Multiple Sclerosis Journal

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1851-1859

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458514534513

21 January 2018

Natalizumab plus interferon beta-1a for relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458514534513

21 January 2018

Natalizumab and progressive multifocal leukoencephalopathy: what are the causal factors and can it be avoided?

1 reference

https://api.crossref.org/works/10.1177%2F1352458514534513

21 January 2018

Risk of natalizumab-associated progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1177%2F1352458514534513

21 January 2018

Revisiting the principles of microRNA target recognition and mode of action

1 reference

https://api.crossref.org/works/10.1177%2F1352458514534513

21 January 2018

MicroRNAs within the continuum of postgenomics biomarker discovery

1 reference

https://api.crossref.org/works/10.1177%2F1352458514534513

21 January 2018

The potential role of microRNA-146 in Alzheimer's disease: biomarker or therapeutic target?

1 reference

https://api.crossref.org/works/10.1177%2F1352458514534513

21 January 2018

Altered microRNA expression in B lymphocytes in multiple sclerosis: towards a better understanding of treatment effects.

1 reference

https://api.crossref.org/works/10.1177%2F1352458514534513

21 January 2018

NAViGaTing the micronome--using multiple microRNA prediction databases to identify signalling pathway-associated microRNAs

1 reference

https://api.crossref.org/works/10.1177%2F1352458514534513

21 January 2018

Gene enrichment profiles reveal T-cell development, differentiation, and lineage-specific transcription factors including ZBTB25 as a novel NF-AT repressor

1 reference

https://api.crossref.org/works/10.1177%2F1352458514534513

21 January 2018

ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks

1 reference

https://api.crossref.org/works/10.1177%2F1352458514534513

21 January 2018

Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls

1 reference

https://api.crossref.org/works/10.1177%2F1352458514534513

21 January 2018

MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47.

1 reference

https://api.crossref.org/works/10.1177%2F1352458514534513

21 January 2018

MicroRNAs regulate human brain endothelial cell-barrier function in inflammation: implications for multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458514534513

21 January 2018

Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458514534513

21 January 2018

MicroRNAs may solve the mystery of chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1177%2F1352458514534513

21 January 2018

L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients.

1 reference

https://api.crossref.org/works/10.1177%2F1352458514534513

21 January 2018

Long-term follow-up of peripheral lymphocyte subsets in a cohort of multiple sclerosis patients treated with natalizumab

1 reference

https://api.crossref.org/works/10.1177%2F1352458514534513

21 January 2018

Identifiers

10.1177/1352458514534513

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46490039&oldid=1744811987"